Reuters: Regulatory News: FDA warns Covidien on violations related to patient deaths

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

FDA warns Covidien on violations related to patient deaths Jun 26th 2012, 18:28 June 26 | Tue Jun 26, 2012 2:28pm EDT June 26 (Reuters) - U.S. health regulators censured Covidien Plc for failing to promptly address complaints related to deaths and serious injuries linked to its devices used in thoracic surgery. Covidien in January said it would recall all production lots of its Duet TRS units, after it received reports of 13 serious injuries and three deaths. The U.S. Food and Drug Administration said the company had received numerous complaints related to the use of the product since May 2009. Covidien, however, did not initiate a corrective and preventative action until Jan 19 this year, when an FDA inspection team sought to review data related to the complaints, the regulator said in a warning letter. The company also failed to document investigations into the deaths and serious injuries, the FDA said in the letter dated June 14. "Failure to promptly correct these violations may result in regulatory action being initiated by the FDA without further notice," the FDA wrote. Covidien should investigate and determine the causes of the violations, and take prompt actions to correct the violations and bring the products into compliance, the regulator said. Link this Share this Digg this Email Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions